Erratum to: Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant.
Ahn JS, Kim JY, Kim HJ, Kim YK, Lee SS, Jung SH, Yang DH, Lee JJ, Kim NY, Choi SH, Minden MD, Jung CW, Jang JH, Kim HJ, Moon JH, Sohn SK, Won JH, Kim SH, Kim DD.
Ahn JS, et al. Among authors: jung cw, jung sh.
Ann Hematol. 2016 Jan;95(2):363. doi: 10.1007/s00277-015-2563-0.
Ann Hematol. 2016.
PMID: 26630982
No abstract available.